Hemogenyx Pharmaceuticals Plc (HOPHF)
OTCMKTS
· Delayed Price · Currency is USD
1.240
+1.200 (3,000.00%)
Mar 7, 2025, 4:00 PM EDT
Hemogenyx Pharmaceuticals Market Cap
Hemogenyx Pharmaceuticals has a market cap or net worth of $9.98 million as of April 25, 2025. Its market cap has decreased by -62.99% in one year.
Market Cap
9.98M
Enterprise Value
11.45M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.24
Market Cap Chart
Since October 6, 2017, Hemogenyx Pharmaceuticals's market cap has decreased from 13.93M to 9.98M, a decrease of -28.33%. That is a compound annual growth rate of -4.31%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo Inc. | 1.67B |
SS Innovations International | 1.66B |
Nika Pharmaceuticals | 1.02B |
Veradigm | 704.15M |
Northwest Biotherapeutics | 497.89M |
Elite Pharmaceuticals | 437.70M |
Glass House Brands | 387.66M |
CytoDyn | 293.81M |